期刊文献+

siRNA介导的Bcl-xL基因沉默诱导人乳腺癌细胞凋亡的研究 被引量:1

Inhibition of Bcl-xL gene expression by siRNA induces apo ptosis in MCF-7 cell line
在线阅读 下载PDF
导出
摘要 目的 研究 si RNA(sm all interfering RNA)对 MCF- 7细胞株 Bcl- x L 基因表达的抑制作用及对癌细胞增殖抑制和凋亡诱导作用。方法 体外转录法合成特异针对人 Bcl- x L 基因的 si RNA;荧光标记法标记 Bcl- x Lsi RNA;脂质体法将 si RNA转入 MCF- 7细胞株 ;流式细胞术检测 si RNA的转染效率 ;半定量 RT- PCR法检测si RNA对 Bcl- x L 基因表达的抑制作用 ;MTT法检测 si RNA对细胞生长增殖抑制作用 ;荧光染色法观察 si RNA诱导细胞凋亡的作用。结果  si RNA的转染效率在一定剂量范围内随浓度的增加而增加 ,si RNA转染组 Bcl- x Lm RNA表达水平可下调约 72 % ,在对照组内 m RNA表达水平无明显改变。细胞生长增殖抑制率在一定范围内具有剂量依赖性和时间依赖性。荧光显微镜下观察肿瘤细胞发现 ,si RNA5 0、10 0、2 0 0 nm ol/L 转染组出现典型的凋亡形态学变化。结论 脂质体法对 si RNA的瞬时转染效率较高 ,体外转录合成的 si RNA能特异有效下调 Bcl- x L 基因的表达 ,瞬时转染 Bcl- x L si RNA能有效抑制乳腺癌细胞增殖并诱导其凋亡。低剂量 Bcl- x L si Objective To study the inhibition of Bcl -xL gene expression induced by siRNA in MCF-7 cell line, and the related pr oliferation inhibition and apoptotic induction of MCF-7 cells. Methods siRNA targeting Bcl-xL gene were synthesized using web design software provided by Ambion and the Silencer siRNA construction kit; Fluorescein-lab eled siRNA was done by FAM-Silencer TMsiRNA Labeling Kit; siRNA was t ransfected into MCF-7 cells by Lipofectamine TM2000 reagent; siRNA transf ection efficiencies were analyzed by flow cytometry; The expression of Bcl-xL w as detected by RT-PCR; MTT assay was used to assess the cell growth; Apoptosis of MCF-7 cells was analyzed by fluorescent microscope. Results The expression of Bcl-xL mRNA decreased by 72% in the siRNA transfected MCF- 7, while no significant changes were found in control groups. The inhibitory rat e of cell proliferation depended on time and concentrations to some extent. The typical morphological changes in apoptosis were found by fluorescence staining i n siRNA groups. Conclusions The synthesized siRNA in vitro ca n down-regulate the expression of Bcl-xL, which is associated with growth inhi bition and apoptosis of MCF-7 cells.
出处 《实用肿瘤杂志》 CAS 2005年第1期25-29,共5页 Journal of Practical Oncology
基金 广东省自然科学基金资助项目 (3196 2)
关键词 乳腺肿瘤 基因疗法 RNA 脱噬作用 转染 breast neoplasms gene therapy RNA apop tosis transfection
  • 相关文献

参考文献13

  • 1唐汉钧.乳腺癌的中医临床与实验研究[J].中医药学刊,2003,21(2):168-172. 被引量:57
  • 2陈杰,白春学,张敏.RNA干扰技术在哺乳动物中的应用[J].生物化学与生物物理进展,2003,30(4):650-654. 被引量:16
  • 3何桂蓉,周克元,蔡康荣,梁统,何承伟,张月飞.脂质体介导bcl-x_L反义寡核苷酸对鼻咽癌CNE-2Z细胞株凋亡的影响[J].癌症,2003,22(1):11-15. 被引量:7
  • 4Miyagishi M,Hayashi M,Taira K. Comparison of the suppressive effects of antisense oligonucleatides and siRNAs directed against the same targets in mammalian cells [J]. Antisense Nucleic Acid Drug Dev,2003,13(1):1-7.
  • 5Hammond SM,Caudy AA,Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA [J].Nat Rev Genet, 2001,2(2):110-111.
  • 6Mercatante DR,Mohler JL, Kole R. Cellular response to an antisense-mediated shift Bcl-xL pre-mRNA splicing and antineoplastic agents [J]. J Biol Chem,2002,277 (51 ) : 49374- 49382.
  • 7Fernandez Y,Espana L,Manas S,et al. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance [J]. Cell Death Differ, 2000,7(4):350-359.
  • 8Wang JL, Liu D. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells [J]. Proc Natl Acad Sci USA, 2000,97(13) :7124-7129.
  • 9Degterev A, Lugovskoy A, Cardone M, et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL [J]. Nat Cell Biol,2001,3(2): 173- 182.
  • 10Lebedeva I,Rando R,Ojwang J,et al. Bcl-xL in prostate cancer cell: effects of overexpression and down-regulation on chemosensitivity [J]. Cancer Res,2000,60 (21) : 6052- 6060.

二级参考文献53

共引文献77

同被引文献6

  • 1刘方欣,李晓愚,张玉诺.Bcl-2基因反义寡核苷酸对乳腺癌细胞株药物敏感性的影响[J].中国药业,2004,13(9):25-27. 被引量:2
  • 2Tanaka T,Toujima S,Umesaki N.Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells[J].Oncol Rep,2004,11(3):667-671.
  • 3Tanabe K,Kim R,Inoue H,et al.Antisense Bcl-2 and HER2 oligonucletide treatment of breast cancer cells enhances their sensitivity to anticancer drugs[J].Int J Oncol,2003,22(4):875-881.
  • 4Simes-Wüst AP,Schürpf T,Hall J,et al.Bcl-2/Bcl-xl bispecific antisence treatment sensitizes breast cancinoma cells to doxorubicin,paclitaxel and cyclophosphamide[J].Breast Cancer Res Treat,2002,76(2):157-166.
  • 5Kars MD,Iseri OD,Ural AU,et al.In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells[J].Anticance Res,2007,27(6B):4031-4037.
  • 6Del Bufalo D,Biroccio A,Trisciuoqlio D,et al.Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used[J].Eur J Cancer,2002,38(18):2455-2462.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部